Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Premature Birth Predicted by Immunoassay

By LabMedica International staff writers
Posted on 03 Oct 2012
Print article
A blood test has been developed that can predict the likelihood that women with intact membranes with threatened preterm labor will deliver spontaneously within seven days of sampling.

The test is based on testing maternal serum for specific proteins, using multiplex sandwich immunoassay based on flowmetric multiplex technology, which has been used to analyze multiple inflammatory markers and neurotrophins in maternal serum in women with threatened preterm labor (PTL).

From 1996 to 2005, an international team working at the Sahlgrenska University Hospital (Gothenburg, Sweden) enrolled 142 healthy women without major medical problems. The women were with singleton pregnancies presenting with threatened PTL between 22 weeks plus 0-7 days and 33 weeks plus 6-7 days of gestation. The assays were based on a newly developed blood test that looks at specific proteins in the woman's blood combined with an already established examination that uses ultrasound to measure the length of the cervix.

Only proteins with detectable maternal serum levels in more than 50% of the samples were included in the analyses. Therefore, interleukins (IL) such as IL-1b, IL-2, IL-5, IL-6, and IL-8 were excluded from further analyses. The statistically highest significant values were detected for IL-10, matrix metalloproteinasis-9 (MMP-9) and migration inhibitory factor (MIF). In the prediction model, levels of maternal serum IL-10 were significantly higher in women who delivered preterm within seven days of sampling, compared with women who delivered later. The study also showed that found that levels of maternal serum chemokine (C-C motif) ligand 5 (RANTES) were statistically higher in women who delivered compared with women who delivered later.

Panagiotis Tsiartas, MD, PhDc, the senior author of the study said, "To have time to give the woman cortisone, which speeds up the development of the fetal lungs, it is common practice to delay the delivery by a couple of days with the help of tocolytic treatment or anti-contraction medications. Being able to predict if a woman who comes to the hospital with preterm contractions will actually give birth early and thereby requires follow-up and possible treatment is therefore very important. Statistically, the method can predict with 75% to 80% accuracy if a woman will give birth early." The study was published September 2012 issue of the British Journal of Obstetrics and Gynaecology.

Related Links:

Sahlgrenska University Hospital


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunoassays and Calibrators
QMS Tacrolimus Immunoassays
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.